March 16 (Reuters) - Cannimed Therapeutics Inc CMED.TO
* Cannimed therapeutics inc. Reports financial results for q1 2017
* Q1 loss per share c$0.19 from continuing operations
* Qtrly sales of $3.4 million were 93% higher than in same period of prior year Source text for Eikon: ID:nBw1TWy8Ha Further company coverage: CMED.TO